[1]. Ball N, Teo WP, Chandra S, Chapman J. Parkinson's Disease and the Environment. Front Neurol. 2019 10: 218.
[2]. Caudle WM. Occupational exposures and parkinsonism. Handb Clin Neurol. 2015 131: 225-239.
[3]. Paul KC, Sinsheimer JS, Cockburn M, Bronstein JM, Bordelon Y, Ritz B. Organophosphate pesticides and PON1 L55M in Parkinson's disease progression. Environ Int. 2017 107: 75-81.
[4]. Kaur K, Kaur R. Occupational Pesticide Exposure, Impaired DNA Repair, and Diseases. Indian J Occup Environ Med. 2018 22: 74-81.
[5]. Tangamornsuksan W, Lohitnavy O, Sruamsiri R, et al. Paraquat exposure and Parkinson's disease: A systematic review and meta-analysis. Arch Environ Occup Health. 2019 74: 225-238.
[6]. Nandipati S, Litvan I. Environmental Exposures and Parkinson's Disease. Int J Environ Res Public Health. 2016 13.
[7]. Pezzoli G, Cereda E. Exposure to pesticides or solvents and risk of Parkinson disease. Neurology. 2013 80: 2035-2041.
[8]. Priyadarshi A, Khuder SA, Schaub EA, Shrivastava S. A meta-analysis of Parkinson's disease and exposure to pesticides. Neurotoxicology. 2000 21: 435-440.
[9]. Gunnarsson LG, Bodin L. Parkinson's disease and occupational exposures: a systematic literature review and meta-analyses. Scand J Work Environ Health. 2017 43: 197-209.
[10]. Priyadarshi A, Khuder SA, Schaub EA, Priyadarshi SS. Environmental risk factors and Parkinson's disease: a metaanalysis. Environ Res. 2001 86: 122-127.
[11]. van der Mark M, Brouwer M, Kromhout H, Nijssen P, Huss A, Vermeulen R. Is pesticide use related to Parkinson disease? Some clues to heterogeneity in study results. Environ Health Perspect. 2012 120: 340-347.
[12]. Van Maele-Fabry G, Hoet P, Vilain F, Lison D. Occupational exposure to pesticides and Parkinson's disease: a systematic review and meta-analysis of cohort studies. Environ Int. 2012 46: 30-43.
[13]. Gamache PL, Haj Salem I, Roux-Dubois N, Le Bouthillier J, Gan-Or Z, Dupre N. Exposure to Pesticides and Welding Hastens the Age-at-Onset of Parkinson's Disease. Can J Neurol Sci. 2019: 1-6.
[14]. Caballero M, Amiri S, Denney JT, Monsivais P, Hystad P, Amram O. Estimated Residential Exposure to Agricultural Chemicals and Premature Mortality by Parkinson's Disease in Washington State. Int J Environ Res Public Health. 2018 15.
[15]. Macleod AD, Taylor KS, Counsell CE. Mortality in Parkinson's disease: a systematic review and meta-analysis. Mov Disord. 2014 29: 1615-1622.
[16]. Brouwer M, Koeman T, van den Brandt PA, et al. Occupational exposures and Parkinson's disease mortality in a prospective Dutch cohort. Occup Environ Med. 2015 72: 448-455.
[17]. Ritz B, Yu F. Parkinson's disease mortality and pesticide exposure in California 1984-1994. Int J Epidemiol. 2000 29: 323-329.
[18]. Coelho FEA, Lopes LC, Cavalcante RMS, Correa GC, Leduc A. Brazil unwisely gives pesticides a free pass. Science. 2019 365: 552-553.
[19]. Rieck M, Schumacher-Schuh AF, Altmann V, et al. DRD2 haplotype is associated with dyskinesia induced by levodopa therapy in Parkinson's disease patients. Pharmacogenomics. 2012 13: 1701-1710.
[20]. https://www.falecidosnobrasil.org.br/ (accessed July 1, 2019 2019).
[21]. Lamarca R, Alonso J, Gomez G, Munoz A. Left-truncated data with age as time scale: an alternative for survival analysis in the elderly population. J Gerontol A Biol Sci Med Sci. 1998 53: M337-343.
[22]. Korn EL, Graubard BI, Midthune D. Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. Am J Epidemiol. 1997 145: 72-80.
[23]. Yan D, Zhang Y, Liu L, Shi N, Yan H. Pesticide exposure and risk of Parkinson's disease: Dose-response meta-analysis of observational studies. Regul Toxicol Pharmacol. 2018 96: 57-63.
[24]. Krueger PM, Tran MK, Hummer RA, Chang VW. Mortality Attributable to Low Levels of Education in the United States. PLoS One. 2015 10: e0131809.
[25]. Rogers RG, Everett BG, Zajacova A, Hummer RA. Educational degrees and adult mortality risk in the United States. Biodemography Soc Biol. 2010 56: 80-99.
[26]. Sichieri R, de Lolio CA, Correia VR, Everhart JE. Geographical patterns of proportionate mortality for the most common causes of death in Brazil. Rev Saude Publica. 1992 26: 424-430.
[27]. Rogot E, Sorlie PD, Johnson NJ. Life expectancy by employment status, income, and education in the National Longitudinal Mortality Study. Public Health Rep. 1992 107: 457-461.
[28]. Yang F, Johansson AL, Pedersen NL, Fang F, Gatz M, Wirdefeldt K. Socioeconomic status in relation to Parkinson's disease risk and mortality: A population-based prospective study. Medicine (Baltimore). 2016 95: e4337.
[29]. Beard JD, Steege AL, Ju J, Lu J, Luckhaupt SE, Schubauer-Berigan MK. Mortality from Amyotrophic Lateral Sclerosis and Parkinson's Disease Among Different Occupation Groups - United States, 1985-2011. MMWR Morb Mortal Wkly Rep. 2017 66: 718-722.
[30]. Costa J, Lunet N, Santos C, Santos J, Vaz-Carneiro A. Caffeine exposure and the risk of Parkinson's disease: a systematic review and meta-analysis of observational studies. J Alzheimers Dis. 2010 20 Suppl 1: S221-238.
[31]. Hu G, Bidel S, Jousilahti P, Antikainen R, Tuomilehto J. Coffee and tea consumption and the risk of Parkinson's disease. Mov Disord. 2007 22: 2242-2248.
[32]. Abbott RD, Ross GW, White LR, et al. Environmental, life-style, and physical precursors of clinical Parkinson's disease: recent findings from the Honolulu-Asia Aging Study. J Neurol. 2003 250 Suppl 3: III30-39.
[33]. Hernan MA, Takkouche B, Caamano-Isorna F, Gestal-Otero JJ. A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease. Ann Neurol. 2002 52: 276-284.
[34]. Palacios N, Gao X, McCullough ML, et al. Caffeine and risk of Parkinson's disease in a large cohort of men and women. Mov Disord. 2012 27: 1276-1282.
[35]. Paul KC, Chuang YH, Shih IF, et al. The association between lifestyle factors and Parkinson's disease progression and mortality. Mov Disord. 2019 34: 58-66.
[36]. Ma C, Liu Y, Neumann S, Gao X. Nicotine from cigarette smoking and diet and Parkinson disease: a review. Transl Neurodegener. 2017 6: 18.
[37]. Betensky RA, Mandel M. Recognizing the problem of delayed entry in time-to-event studies: Better late than never for clinical neuroscientists. Ann Neurol. 2015 78: 839-844.
[38]. Ferguson LW, Rajput AH, Rajput A. Early-onset vs. Late-onset Parkinson's disease: A Clinical-pathological Study. Can J Neurol Sci. 2016 43: 113-119.